0214 (0214) Fair Value & Analysis

Financial Services · Market cap HK$160M

0 0214 0214 · HK

PriceHK$0.1900

Fair ValueHK$0.1487

Upside-21.7%

Quality48/100

Evidence: Low Range HK$0.1487 – HK$0.4500

Fair value as of: Jul 1, 2026

From 6 valuation models · updated today

Share price −25.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1900 – HK$0.3550 · fair‑value band HK$0.1487 – HK$0.4500 · the HK$0.1900 price screens above the HK$0.1487 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0214 (0214) currently trades at HK$0.1900, while our model-based Fair Value estimate is HK$0.1487 — implying the stock looks roughly 21.7% overvalued today. We read business quality at 48/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0214 generated revenue of HK$6.3B at a net margin of -35.4%. Revenue grew 229.9% year over year. It earns a return on equity of -25.4%. Net debt stands at HK$15.0B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$6.3B

Revenue growth (YoY) +230%

Net margin -35.4%

Return on equity -25.4%

Free cash flow HK$2.1B FY2025

Operating margin 12.8%

More key figures

EPS (TTM) HK$-2.38

EPS growth (YoY) -90.8%

Net debt HK$15.0B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0214 reported revenue of HK$2.5B in FY2025 versus HK$2.7B in FY2021, a compound −2.2%/yr. Reported net income was −HK$2.2B in FY2025.

Revenue −2.2%/yr

FY21 HK$2.7B

FY22 HK$2.8B

FY23 HK$2.3B

FY24 HK$1.9B

FY25 HK$2.5B

Net income

FY21 HK$1.0B

FY22 −HK$906M

FY23 HK$429M

FY24 −HK$3.8B

FY25 −HK$2.2B

Is 0214 fairly valued? → Check now

Similar stocks

6 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Fondul Proprietatea SA FP	$4.20	$6.41	+53%
The Schiehallion Fund Limited MNTN	$2.27	$4.54	+100%
BlackRock, Inc BLK	17,417 MXN	10,294 MXN	-41%
BH Macro Limited BHMU	$0.0442	$0.0900	+104%
Blackstone Inc BX	$118.55	$61.04	-49%
Investor AB IVSBF	$39.99	$79.98	+100%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0214 (0214) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.1487 versus a price of HK$0.1900 — about −22% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0214?

Our model-based fair value for 0214 is HK$0.1487 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.1900.

What is the quality score of 0214?

0214 has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0214 (0214)?

0214 reported trailing-twelve-month revenue of about HK$6.3B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0214?

The net profit margin of 0214 is about -35.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.